Indian Journal of Anaesthesia

REVIEW ARTICLE
Year
: 2013  |  Volume : 57  |  Issue : 2  |  Page : 127--134

Scrub typhus


Amy G Rapsang, Prithwis Bhattacharyya 
 Department of Anesthesiology and Intensive Care, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS) Campus, Shillong, Meghalaya, India

Correspondence Address:
Prithwis Bhattacharyya
North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences Campus, Shillong, Meghalaya
India

Abstract

Scrub typhus is an acute febrile illness caused by orientia tsutsugamushi, transmitted to humans by the bite of the larva of trombiculid mites. It causes a disseminated vasculitic and perivascular inflammatory lesions resulting in significant vascular leakage and end-organ injury. It affects people of all ages and even though scrub typhus in pregnancy is uncommon, it is associated with increased foetal loss, preterm delivery, and small for gestational age infants. After an incubation period of 6-21 days, onset is characterized by fever, headache, myalgia, cough, and gastrointestinal symptoms. A primary papular lesion which later crusts to form a flat black eschar, may be present. If untreated, serious complications may occur involving various organs. Laboratory studies usually reveal leukopenia, thrombocytopenia, deranged hepatic and renal function, proteinuria and reticulonodular infiltrate. Owing to the potential for severe complications, diagnosis, and decision to initiate treatment should be based on clinical suspicion and confirmed by serologic tests. A therapeutic trial of tetracycline or chloramphenicol is indicated in patients in whom the diagnosis of scrub typhus is suspected. The recommended treatment regimen for scrub typhus is doxycycline. Alternative regimens include tetracycline, chloramphenicol, azithromycin, ciprofloxacin, rifampicin, and roxithromycin. Treatment of pregnant women with azithromycin was successfully done without relapse and with favorable pregnancy outcomes. Hence, early diagnosis and treatment are essential in order to reduce the mortality and the complications associated with the disease. We searched the English-language literature for reports of scrub typhus in children, pregnant women, and non-pregnant patients with scrub typhus, using the MEDLINE/PubMed database, which includes citations from 1945 to the present time. We used the search terms «SQ»scrub typhus«SQ», «SQ»scrub typhus«SQ» and «SQ»pregnancy«SQ», «SQ»scrub typhus«SQ» and «SQ»children«SQ», «SQ»scrub typhus«SQ» and «SQ»complications«SQ», «SQ»scrub typhus«SQ» and «SQ»treatment«SQ».



How to cite this article:
Rapsang AG, Bhattacharyya P. Scrub typhus.Indian J Anaesth 2013;57:127-134


How to cite this URL:
Rapsang AG, Bhattacharyya P. Scrub typhus. Indian J Anaesth [serial online] 2013 [cited 2019 Nov 20 ];57:127-134
Available from: http://www.ijaweb.org/text.asp?2013/57/2/127/111835


Full Text

 Introduction



Also known as tsutsugamushi disease, [1] this acute febrile disease is caused by orientia tsutsugamushi [Japanese word tsutsuga ("dangerous"), mushi ("bug")], [1] which is a small Gram-negative, obligate intracellular organism whose polysaccharides bear an antigenic relationship to proteus OX-K, which is thus used in serologic tests to confirm scrub typhus. [1] O. tsutsugamushi is transmitted to humans by the bite of the larva of trombiculid mites (chiggers) which are almost microscopic, often brilliantly colored (red). [1] Infected chiggers are found particularly in areas of heavy scrub vegetation during the wet season, (therefore this disease has also been called river/flood fever [1] ) when mites lay eggs. [2] usually June through November. [3] The word "scrub" was applied because of the type of vegetation that maintains the chigger−mammal relationship even though other regions also support rodents and mites. [1]

Scrub typhus is endemic to a part of the world known as the ''tsutsugamushi triangle.'' This extends from Japan, Taiwan, China, South Korea, [4] Nepal, Northern Pakistan, Papua New Guinea, and the Australian states of Queensland and Northern New South Wales. [5] In India, the presence of scrub typhus has been known for several years. The disease is widely spread all over the country, and was reported in several states - Haryana, Jammu, and Kashmir, Himachal Pradesh, Uttaranchal, West Bengal, Assam, Maharashtra, Kerala and Tamilnadu. [6] During World War II, there was an outbreak of this disease in Assam and West Bengal, in the 1965 Indo-Pak war and in 1990 and in a unit of an army deployed at the Pakistan border of India. [7] These reports showed a resurgence of this disease in India.

O. tsutsugamushi invades endothelial cells to produce disseminated vasculitic and perivascular inflammatory lesions, which results in significant vascular leakage and ensuing end-organ injury. [1],[3]

 Clinical Features and Diagnosis



Illness varies from mild and self-limiting to fatal. [2] After an incubation period of 6-21 days, onset is characterized by fever, headache, myalgia, cough, and gastrointestinal symptoms. [1] The classic case description includes a primary papular lesion (where the chigger has fed and can occur anywhere on the body), which enlarges, undergoes central necrosis, and crusts to form a flat black eschar. This is associated with regional and later generalized lymphadenopathy (enlarged and tender nodes). The symptoms gradually increase in severity and a macular rash may appear on the trunk. [8] If untreated, the patient may become stuporous as meningoencephalitis develops. Various cranial nerve deficits have been noted in untreated patients. [3] Pulmonary findings are often absent despite radiographic evidence of interstitial pneumonia. Signs of cardiac dysfunction, including minor electrocardiographic abnormalities - first-degree heart block and inverted T waves - can appear. In patients with myocarditis, there may be a gallop rhythm, poor-quality heart sounds, and systolic murmurs. [3] Sometimes, palpable spleen (and occasionally liver) may also be present. Deafness, dysarthria, and dysphagia may occur but are usually transient, although deafness can last for several months. Patients with untreated disease remain febrile for about 2 weeks and have a long convalescence of 4 to 6 weeks thereafter. [1]

In children, scrub typhus may be mild or severe. Most patients present with fever and regional/generalized lymphadenopathy. A single painless eschar, maculopapular rash [3] hepatomegaly, splenomegaly and gastrointestinal symptoms (abdominal pain, vomiting, and diarrhoea) may be present. Case fatality rate in untreated patients may be as high as 30%, although deaths in children are infrequent. [3]

It is necessary to determine the predictors that identify markers of severe disease in order to reduce the mortality, complications and the delay in treatment. The potential markers for developing complications were age (≥60 years); scrub typhus patients who presented to the hospital without an eschar; laboratory findings such as WBC counts >10, 000/mm and serum albumin level ≤3.0 g/dL. [3],[9]

Laboratory studies usually revealed:

Leukopenia [1] and thrombocytopenia [3] with subsequent increase of white blood cell counts to normal levels. [1] In children, leukocyte and platelet counts are usually within normal ranges, although thrombocytopenia and leukocytosis may also occur [3]Coagulopathy [1]Elevation of liver enzymes and bilirubin - indicating hepatocellular damage [1]Proteinuria [1]Elevation of creatinine [3]Reticulonodular infiltrates (most common finding on chest radiograph). [8] Chest X-rays also reveal transient perihilar or peribronchial interstitial infiltrates [3]Cerebrospinal fluid (CSF) examinations show a mild mononuclear pleocytosis with normal glucose levels. [3]Owing to the potential for severe complications, diagnosis, and decision to initiate treatment should be based on clinical suspicion and confirmed by serologic tests. [3] Serological tests have their own limitations in which clinicians need to be aware of. Although agreement exists that a ≥ four-fold increase in antibody titre between two consecutive samples is diagnostic, such a diagnosis is retrospective and cannot guide initial treatment. [10],[11]

Weil-Felix

The Weil-Felix agglutination test, oldest test in current use, detects cross-reacting antibodies to proteus mirabilis OXK. [12] Diagnostic Weil-Felix agglutination (detectable after 5 to 10 days following the onset) [6] shows ≥four times rise in titre to proteus OX-K and no reaction to proteus OX-2 or OX-19 (in 50-70% of patients); a single titre ≥1:160 is also diagnostic (normal is ≤1:40.). [13] About 50% of patients have diagnostic titres. [1],[3] This test is inexpensive, easy to perform, and results are available overnight; however, it lacks specificity and sensitivity. [11] The Weil-Felix test is still used because of its low cost, [12] and in conditions where other serologic tests are not available/possible e.g., in rural areas. Even though this test is not a very sensitive test but when positive, it is rather specific test. [14]

 Enzyme-Linked Immunosorbent Assay



Kits for the detection of antibodies against infectious agents use pooled human sera as reference material to establish cut-off values and to routinely confirm test integrity. [15] The 56-kDa protein (located on the outer membrane of O. Tsutsugamushi) is highly reactive with patient sera, and therefore preferred for use in the diagnosis of scrub typhus. [16] ELISA using whole cell antigen and r56 from the Karp, Kato, and Gilliam strains of O. Tsutsugamushi (KpKtGm-wc ELISA and KpKtGm r56 ELISA) [17],[18] were used and the final concentrations of antibodies were then measured by a Microplate Reader. In a study by Jiang et al., [17] this trivalent ELISA appears to be superior in terms of sensitivity, to the other ELISA tests, owing to the presence of large amounts of conserved and/or variable regions of the r56-kD protein from the three strains of O. Tsutsugamushi. Jones et al., [19] described genetically engineered chimeric IgG, IgM, and IgA antibodies as an alternative positive control for inclusion in a commercial ELISA kit, and found that the purified protein have a much greater specificity for the scrub typhus antigen than the serum-derived controls. Jang et al. [16] described a rapid and reliable IgM capture ELISA based on the capture of IgM antibodies in sera, and concluded that IgM capture ELISA carries a high sensitivity and specificity. It is also a reliable and useful diagnostic method for early detection of scrub typhus, besides a large number of sera can be tested at a time.

 Rapid Lateral Flow-Assay



Consists of a single strip (IgG, IgM), where the Kp r56 protein was conjugated to gold particles as the indicator system. [17],[20]

 Western Blot



Assay r56 from the Karp, Kato, and Gilliam strains of O. Tsutsugamushi (KpKtGm r56), [17] using electrophoresis. Results are interpreted as positive or negative with the presence or the absence of a 41-kD band (for the truncated 56-kD recombinant protein) on the film, respectively.

 Immunochromatographic Test



A rapid diagnostic test in which serum was applied to the reagent pad of the ICT strip. The results were recorded as positive, equivocal, or negative for the presence of the control and the IgM or total antibody lines. Blacksell et al. [21] assessed the diagnostic capacity of a rapid ICT and found that the sensitivity and specificity for the detection of IgM were 96.8 and 93.3%, respectively. For the detection of total antibodies, the sensitivity was 97.6% but the specificity was much lower, at 71.4%.

 The Indirect Fluorescent Assay



First described by Bozeman et al. 1963. [22] IFA has been considered as the gold standard for serologic detection of scrub typhus antibodies, [23] and is also currently the reference standard. [10] The specific serologic test for a conclusive diagnosis is the detection of significant increases (≥four-fold) of IFAs in paired serum specimens obtained 2 weeks apart. [1] The end point of each IFA titre was defined as the lowest serum concentration demonstrating definite fluorescence. The test is more sensitive and faster but costly and antigenic variation is common. [11]

 Indirect Immunoperoxidase



Eliminates the expense of a fluorescent microscope in which fluorescein is replaced by peroxidise. [24] This test has the advantage in that any rickettsial strain can be used as the antigen, either IgG or IgM antibodies can be titrated individually, gives a permanent preparation (for re-examination), and all cells (infected and uninfected) can be observed. It is easy, however the readings are subjective. [25]

 PCR Amplification of Orientia Genes



Samples from eschars and blood are useful, and may be the most sensitive diagnostic test. [3] Since O. tsutsugamushi is an intracellular organism, thus whole blood or the buffy coat is considered to be the preferred samples for PCR tests. [26] Nested PCR test, based on specific primers derived from the 56-kDa major outer membrane protein antigen of O. Tsutsugamushi, can detect the organism as early as 1-3 days of the fever phase and is known to be 100 times more sensitive than performing single PCR. [26],[27],[28]

 Isolation/Inoculation



O. tsutsugamushi can be isolated and cultured from a patient's blood by inoculating it intraperitoneally, into white mice. However, it requires biosafety level-3 facilities, [29] costly and laborious, hence not appropriate for the routine diagnosis of scrub typhus. [11] Guinea pig inoculation - scrotal reaction following intra peritoneal injection of blood into male guinea pig. (Test is often not used at present.) - Negative in scrub typhus. [13] [Table 1] shows a list of diagnostic tests for scrub typhus.{Table 1}

Complications

Scrub typhus involves multiple organs and is characterized by microangiopathies - focal vasculitis or perivasculitis. [1] Pulmonary involvement is a well-documented complication of scrub typhus infection with pleural effusion being a common radiographic feature in 12-55% of patients in previous studies. [1],[2],[30] Other pulmonary manifestations include varying degrees of bronchitis/interstitial pneumonitis progressing to acute respiratory distress syndrome, [9] pneumonitis with patchy consolidation, cardiomegaly, pulmonary oedema, hilar adenopathy, focal atelectasis, reticulonodular opacities, bronchial wall thickening, and centrilobular nodules. [1],[2] Radiologic findings may be of value in differentiating scrub typhus from other febrile diseases. The incidence of CXR abnormalities in patients with scrub typhus varied from 59.4 to 78%. [1],[2],[3],[31] In their study, Wu et al., [32] found that the incidence of CXR abnormalities was higher in the older age groups and that the CXR patterns could be different at different stages of the same disease. Patients with abnormal CXR findings had a higher rate of serious complications (such as septic shock, congestive heart failure (CHF), acute respiratory failure, severe jaundice and acute renal failure, and requirement for ICU care and prolonged length of hospital stay) compared with patients with negative CXR results. [32]

 Scrub Typhus and Acute Respiratory Distress Syndrome



ARDS (defined as an acute and persistent lung inflammation with increased vascular permeability) [33] is a well known complication of scrub typhus, which is rarely reported but serious. [34] Initial symptoms of dyspnea and cough, higher WBC counts, lower hematocrit, higher total bilirubin counts, and delayed treatment with appropriate antibiotics were significantly predictive variables in these patients; with albumin, prothrombin time, and delayed use of appropriate antibiotics being independent predictors. [35] The risk factors for the development of ARDS are older age, thrombocytopenia, and the presence of early pneumonitis. [34] The major cause of mortality is a delay in diagnosis, but with appropriate antibiotic therapy, patients usually recover without any major sequelae. [34] In a study by Wang et al., [35] 11.1% of their scrub typhus patients developed ARDS, and the mortality rate for such patients was 25%. Pandey et al., [36] reported three cases of scrub typhus with ARDS who showed dramatic response to doxycycline. Hence, scrub typhus patients should be carefully evaluated for potential progression to ARDS if they initially have respiratory symptoms.

Myocarditis in scrub typhus is usually subclinical and therefore many times ignored. [37] The main pathologic findings are vasculitis, perivasculitis, and cellular infiltrations consisting of primarily lymphocytes and plasma cells, with interstitial haemorrhage and oedema. [38] Cardiomegaly and CHF may be present, which could be secondary to myocardial or pericardial involvement.

Gastrointestinal involvement is also frequently reported. [32],[39] Some studies reported elevation of liver enzymes [37] and hepatic dysfunction [40] with elevation of serum bilirubin. [40] Most patients showed a peak value in their abnormal liver function tests 2 weeks after the onset of symptoms. [40] The major endoscopic features in scrub typhus are superficial mucosal haemorrhage, multiple erosions, and ulcers without any preferred site, and unusual vascular bleeding. [39] Acute pancreatitis associated with pancreatic abscess in a patient with multiple organ failure has been reported. [41] The mechanism responsible for the development of acute pancreatitis may involve an intrinsic inflammatory process via vasculitis, but the precise nature of this mechanism is not well understood. [42] Hyperamylasemia and hyperlipasemia have also been reported. [32],[43]

Many studies [32],[41] reported renal failure as one of the major complications. One study showed that during the febrile phase of the illness, 20% of the patients had abnormal urinalysis, showing proteinuria almost exclusively. [44] The renal pathology usually shows characteristic focal interstitial lesions, cloudy swelling of the tubular epithelium, occasional evidence of severe vascular damage, and glomerular injury. [45]

Central nervous system (CNS) complications range from aseptic meningitis to frank meningoencephalitis. Meningoencephalitis is a constant autopsy finding in fatal cases of scrub typhus, and is present in 10% of children. [3] Pai and co-workers [46] have even demonstrated amplified O. tsutsugamushi DNA in CSF specimens by means of nested PCR. Other studies [32] reported slight pleocytosis with mild protein elevation and normal sugar values in CSF. In other series involving small numbers of pediatric patients (15-30 patients), aseptic meningitis ranged from 3 to 20%. [42],[47]

Multi organ failure was also reported in various studies. [37],[43]

 Differential Diagnosis



Scrub typhus is a recognized cause of obscure tropical fevers, especially in children. [4] The differential diagnosis includes fever of unknown origin, enteric fever, typhoid fever, dengue hemorrhagic fever, other rickettsioses, tularemia, anthrax, dengue, leptospirosis, malaria, hemorrhagic fevers, and infectious mononucleosis. [3] The headache may mimic trigeminal neuralgia. [8]

Prognosis, treatment, prevention and control

The case-fatality rate for untreated classic cases is 7% but would probably be lower if all mild cases were diagnosed. [2] Poor prognostic factors include requiring care in an intensive care unit, high APACHE-II scores, and the absence of an eschar (making diagnosis more difficult). [8] According to some reports, the rate of eschar formation varies [48],[49] and is much less in the Indian subcontinent, [49] and could be related to the different virulence, load of pathogen, and host immunity. Concurrent scrub typhus may inhibit the replication of HIV [3] and HIV infection does not appear to influence the severity of scrub typhus. [8]

A therapeutic trial of tetracycline or chloramphenicol is indicated in patients in whom the diagnosis of scrub typhus is suspected. Defervescence should occur within 24 h. The recommended treatment regimen for scrub typhus is doxycycline (2.2 mg/kg/dose bid PO or IV, maximum 200 mg/day for 7-15 days). [2],[3] For prophylaxis, 200 mg may be taken as a single dose. In patients in whom oral therapy is not feasible, it may be given as the hyclate by slow intravenous infusion. [50] It does not accumulate significantly in patients with renal impairment. [50] Recent reports suggest that natural resistance to doxycycline and other antibiotics make selection of appropriate antimicrobial therapy difficult. [3]

Alternative regimens include tetracycline (25-50 mg/kg/day divided every 6 h PO, maximum 2 g/day) or chloramphenicol (50-100 mg/kg/day divided every 6 h IV, maximum 3 g/24 h, or 500 mg qid orally for 7-15 days for adults). If used, chloramphenicol should be monitored to maintain serum concentrations of 10-30 μg/mL. [3] Therapy should be continued for a minimum of 5 days and until the patient has been afebrile for at least 3-4 days to avoid relapse. [3] Chloramphenicol is best avoided during pregnancy and reduced doses should be given in hepatic impairment. [50]

Ciprofloxacin is a quinolone antibiotic that is effective against O. Tsutsugamushi. However, there is a substantial amount of data demonstrating that ciprofloxacin is not efficacious in the treatment of scrub typhus. [51] Another alternative is azithromycin (500 mg orally for 3 days). Clinical trials showed that azithromycin may be as effective, and that rifampicin (600 to 900 mg/day) is superior to doxycycline in such cases. A retrospective analysis in Korean children with scrub typhus showed that roxithromycin (150 mg twice a day) was as effective as either doxycycline or chloramphenicol, suggesting a role as an alternative therapy for children or pregnant women. [3] Rifampin reduces the duration of fever by 1 day when used with doxycycline. [8] Intensive care may be required for haemodynamic management of severely affected individuals. [3]

Prevention is based on avoidance of the chiggers that transmit O. Tsutsugamushi, accomplished by insect repellents and by the use of protective clothing impregnated with benzyl benzoate. [1] Diethyltoluamide preparations are also effective and applying this chemical to socks is especially important in preventing chigger bites. [1] Infection provides immunity to reinfection by homologous but not heterologous strains; however, since natural strains are highly heterogeneous, infection does not always provide complete protection against reinfection. [3] Vaccines were developed and tested, however, no single antigen has been identified that induces protection against all of the antigenically diverse strains of O. tsutsugamushi. [1] For short exposure, chemoprophylaxis with doxycycline (200 mg weekly) can prevent the disease but permits infection. [8] Prophylaxis for scrub typhus with doxycycline has shown promise when started before exposure to infection.

 Scrub Typhus in Pregnancy



The clinical manifestations of scrub typhus in pregnant women are similar to those of non-pregnant adults. [52] Studies reported that scrub typhus in pregnancy may be associated with increased foetal loss, [51],[52] preterm delivery, [52],[53] and small for gestational age infants. [51] There have been reports of vertical transmission [53],[54] from transplacental infection and transmission in perinatal blood-borne infection during labor [54] causing neonatal scrub typhus in mothers with acute febrile illness during pregnancy. Diagnosis of scrub typhus during pregnancy is same as in non-pregnant women and is based on an exposure history, clinical symptoms, and confirmed serological studies. [52] The standard therapy for scrub typhus in non-pregnant adults is doxycycline and chloramphenicol. However, doxycycline, a class D drug (according to the U.S. Food and Drug Administration), has been associated with fetal risk and is contraindicated in pregnant women. One study reported a pregnant woman who had received chloramphenicol, and despite the mother's high scrub typhus-specific IgG and IgM titers, IgM was not detected in the neonate's sera. [52] However, chloramphenicol, is classified as a class C drug and is prescribed with caution to late trimester pregnant women because of increase risk to the foetus at the time of delivery. [55] Tsui and co-workers [56] reported a pregnant woman who was successfully treated with minocycline, but it is difficult to define the safety of its use during pregnancy from this single limited report. Single dose of azithromycin 500 mg was successfully used in nine pregnant women suffering from scrub typhus without relapse and with favorable pregnancy outcomes. [57] Importantly, there is little evidence to suggest that azithromycin causes harm to the developing foetus. [58] Azithromycin seems to be an effective agent against scrub typhus because it efficiently penetrates polymorphonuclear leukocytes and macrophages, which are target cells for O. tsutsugamushi. [59] In addition, a long tissue half-life and long lasting post-antibiotic effects of azithromycin may explain no relapse despite the use of a single dose. The use of ciprofloxacin in pregnant women resulted in miscarriages; [51] therefore, ciprofloxacin should be selected with caution for the treatment of scrub typhus, especially during pregnancy.

Relevance to clinical anesthesiologists/intensivists

Scrub typhus is a killer disease where disseminated vasculitic and perivascular inflammatory lesions result in end-organ injury. Even though the disease shows dramatic response to appropriate antibiotics, these serious complications can occur and most of them proved to be fatal. In most of the intensive care units (ICU), these patients are usually admitted when such complications have already progressed, mainly due to undiagnosis/misdiagnosis and hence left un-treated. In the ICU, aggressive management (like appropriate ventilator strategy in ARDS patients, dialysis of renal failure patients, correction of haematological abnormalities etc.) of such patients is imperative to prevent the high mortality associated with these complications. Preventing sepsis and multi organ failure can be possible in the ICU with specific treatment protocols and supportive management. Hence, an anesthetist/intensivist have to be aware of such situations to prevent morbidity and mortality associated with this disease.

 Conclusion



Scrub typhus is a growing and emerging disease, which is grossly under-diagnosed in under developed/developing countries due to its non-specific clinical presentation, limited awareness, and low index of suspicion among clinicians and lack of diagnostic facilities. Hence, early diagnosis and treatment are imperative to reduce the mortality and the complications associated with the disease.

References

1Hornick RB. Rickettsial Diseases. (Chapter 371). In: Bennett JC, Plum F, editors. Goldman: Cecil Textbook of Medicine. 21 st ed. Philadelphia, USA: WB Saunders Company; 2000. p. 1911-2.
2Walker DH, Dumler JS, Marrie T. Rickettsial Diseases. (Part 8, Section 10, Chapter 174) In: Longo DL, Fauci AS Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's Principle of Internal Medicine. 18 th ed. USA: The McGraw-Hill Companies; 2012. p. 1064-5.
3Dumler JS, Siberry GK. Scrub Typhus (Orientia Tsutsugamushi). (Part XVI. Section 11. Chapter 226). In: Kliegman RM, Behrman Re, Jenson HB, Stanton BF, editors. Nelson Textbook of Pediatrics. 18 th ed. Philadelphia: Saunders, Elsevier; 2007. p. 1295-6.
4Chang WH. Current status of tsutsugamushi disease in Korea. J Korean Med Sci 1995;10:227-38.
5Mahajan SK. Scrub typhus. J Assoc Physicians India 2005;53:954-8.
6Mahajan SK, Kashyap R, Kanga A, Sharma V, Prasher BS, Pal LS. Relevance of Weil-Felix test in diagnosis of scrub typhus in India. J Assoc Physicians India 2006;54:619-21.
7Singh P. Scrub typhus, a case report: Military and regional significance. Med J Armed Forces India 2004;60:89-90.
8Corrales-Medina VF, Shandera W ×. Viral-Rickettsial Infections (Chapter 32). In: Mc Phee SJ, Papadakis MA, editors. Current Medical Diagnosis and Treatment. 50 th ed. USA: Mc Graw Hill companies; 2011. p. 1283.
9Kim D, Kim SW, Choi SH, Yun NR. Clinical and laboratory findings associated with severe scrub typhus. BMC Infect Dis 2010;10:108.
10Blacksell SD, Bryant NJ, Paris DH, Doust JA, Sakoda Y, Day NP. Scrub typhus serologic testing with the indirect immunofluorescence method as a diagnostic gold standard: A lack of consensus leads to a lot of confusion. Clin Infect Dis 2007;44:391-401.
11Koh GC, Maude RJ, Paris DH, Newton PN, Blacksell SD. Diagnosis of scrub typhus. Am J Trop Med Hyg 2010;82:368-70.
12Raoult D. Orientia tsutsugamushi. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 7 th ed. Philadelphia: Churchill Livingstone; 2009. p. 2529-30.
13Wallach J. Interpretation of diagnostic tests. 8 th ed. Philadelphia: Lippincott Williams and Wilkins; 2009. p. 950.
14Saah AJ. Orientia tsutsugamushi (Scrub Typhus). In: Mandell GL, Bennet JE, Doalin R, editors. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2000. p. 2056-7.
15Jacobson RH. Validation of serological assays for diagnosis of infectious diseases. Rev Sci Tech 1998;17:469-526.
16Jang WJ, Huh MS, Park KH, Choi MS, Kim IS. Evaluation of an immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Orientia tsutsugamushi infection. Clin Diagn Lab Immunol 2003;10:394-8.
17Jiang J, Marienau KJ, May LA, Beecham HJ, Wilkinson R, Ching WM, et al. Laboratory diagnosis of two scrub typhus outbreaks at camp Fuji, Japan in 2000 and 2001 by enzyme-linked immunosorbent assay, rapid flow assay, and western blot assay using outer membrane 56-kd recombinant proteins. Am J Trop Med Hyg 2003;69:60-6.
18Dasch GA, Halle S, Bourgeosis AL. Sensitive microplate enzyme-linked immunosorbent assay for detection of antibodies against scrub typhus rickettsia, Rickettsia tsutsugamushi. J Clin Microbiol 1979;9:38-48.
19Jones ML, Barnard RT. Use of chimeric antibodies as positive controls in an enzyme-linked immunosorbent assay for diagnosis of scrub typhus (infection by Orientia tsutsugamushi). Clin Vaccine Immunol 2007;14:1307-10.
20Wilkinson R, Rowland D, Ching WM. Development of an improved rapid lateral flowassay for the detection of Orientia tsutsugamushi specific IgG/IgM antibodies. Ann N Y Acad Sci 2003;990:386-90.
21Blacksell SD, Jenjaroen K, Phetsouvanh R, Wuthiekanun V, Day NP, Newton PN, et al. Accuracy of AccessBio Immunoglobulin M and Total Antibody Rapid Immunochromatographic Assays for the Diagnosis of Acute Scrub Typhus Infection. Clin Vaccine Immunol 2010;17:263-6.
22Bozeman FM, Elisberg BL. Serological diagnosis of scrub typhus by indirect immunofluorescence. Proc Soc Exp Biol Med 1963;112:568-73.
23La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: Current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 1997;35:2715-27.
24Kelly DJ, Wong PW, Gan E, Lewis GE. Comparative evaluation of the indirect immunoperoxidase test for the serodiagnosis of rickettsial disease. Am J Trop Med Hyg 1988;38:400-6.
25Yamamoto S, Minamishima Y. Serodiagnosis of tsutsugamushi fever (scrub typhus) by the indirect immunoperoxidase technique. J Clin Microbiol 1982;15:1128-32.
26Kim D, Yun NR, Yang TY, Lee JH, Yang JT, Shim S, et al. Usefulness of nested PCR for the diagnosis of scrub typhus in clinical practice: A prospective study. Am J Trop Med Hyg 2006;75:542-5.
27Manosroi J, Chutipongvivate S, Auwanit W, Manosroi A. Early diagnosis of scrub typhus in Thailand from clinical specimens by nested polymerase chain reaction. Southeast Asian J Trop Med Public Health 2003;34:831-8.
28Murai K, Tachibana N, Okayama A, Shishime E, Tsuda K, Oshikawa T. Sensitivity of polymerase chain reaction assay for Rickettsia tsutsugamushi in patients' blood samples. Microbiol Immunol 1992;36:1145-53.
29Luksameetanasan R, Blacksell SD, Kalambaheti T, Wuthiekanun V, Chierakul W, Chueasuwanchai S, et al. Patient and sample-related factors that effect the success of in vitro isolation of Orientia tsutsugamushi. Southeast Asian J Trop Med Public Health 2007;38:91-6.
30Fournier PE, Siritantikorn S, Rolain JM, Suputtamongkol Y, Hoontrakul S, Charoenwat S, et al. Detection of new genotypes of Orientia tsutsugamushi infecting humans in Thailand. Clin Microbiol Infect 2008;14:168-73.
31Silpapojakul K. Scrub typhus in the Western Pacific region. Ann Acad Med Singapore 1997;26:794-800.
32Wu KM, Wu ZW, Peng ZQ, Wu JL, Lee SY. Radiologic pulmonary findings, clinical manifestations and serious complications in scrub typhus: Experiences from a teaching hospital in eastern Taiwan. INT J Gerontol 2009;3:223-32.
33Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
34Tsay RW, Chang FY. Acute respiratory distress syndrome in scrub typhus. QJM 2002;95:126-8.
35Wang CC, Liu SF, Liu JW, Chung YH, Su MC, Lin MC. Acute respiratory distress syndrome in scrub typhus. Am J Trop Med Hyg 2007;76:1148-52.
36Pandey D, Sharma B, Chauhan V, Mokta J, Verma BS, Thakur S. ARDS complicating scrub typhus in Sub-Himalayan region. J Assoc Physicians India 2006;54:812-3.
37Tsay RW, Chang FY. Serious complications in scrub typhus. J Microbiol Immunol Infect 1998;31:240-4.
38Levine HD. Pathologic study of thirty-one cases of scrub typhus fever with especial reference to cardiovascular system. Am Heart J 1946;31:314-28.
39Kim SJ, Chung IK, Chung IS, Song DH, Park SH, Kim HS, et al. The clinical significance of upper gastrointestinal endoscopy in gastrointestinal vasculitis related to scrub typhus. Endoscopy 2000;32:950-5.
40Yang CH, Hsu GJ, Peng MY, Young TG. Hepatic dysfunction in scrub typhus. J Formos Med Assoc 1995;94:101-5.
41Yi SY, Tae JH. Pancreatic abscess following scrub typhus associated with multiorgan failure. World J Gastroenterol 2007;13:3523-5.
42Yang SH, Ho YH, Chu CH, Chu SY. Childhood scrub typhus in eastern Taiwan: Ten-year experience from a medical center. Acta Paediatr Taiwan 2007;48:332-6.
43Chi WC, Huang JJ, Sung JM, Lan RR, Ko WC, Chen FF. Scrub typhus associated with multiorgan failure: A case report. Scand J Infect Dis 1997;29:634-5.
44Berman SJ, Kundin WD. Scrub typhus in South Vietnam. A study of 87 cases. Ann Intern Med 1973;79:26-30.
45Allen AC, Spitz S. A comparative study of the pathology of scrub typhus (tsutsugamushi disease) and other rickettsial diseases. Am J Pathol 1945;21:603-81.
46Pai H, Sohn S, Seong Y, Kee S, Chang WH, Choe KW. Central nervous system involvement in patients with scrub typhus. Clin Infect Dis 1997;24:436-40.
47Sirisanthana V, Puthanakit T, Sirisanthana T. Epidemiologic, clinical and laboratory features of scrub typhus in thirty Thai children. Pediatr Infect Dis J 2003;22:341-5.
48Sonthayanon P, Chierakul W, Wuthiekanun V, Phimda K, Pukrittayakamee S, Day NP, et al. Association of high Orientia tsutsugamushi DNA loads with disease of greater severity in adults with scrub typhus. J Clin Microbiol 2009;47:430-4.
49Varghese GM, Abraham OC, Mathai D, Thomas K, Aaron R, Kavitha ML, et al. Scrub typhus among hospitalised patients with febrile illness in South India: Magnitude and clinical predictors. J Infect 2006;52:56-60.
50Sweetman SC, editor. Martindale. The complete drug reference. Vol. 1. 35 th ed. Pharmaceutical Press, London 2007; p. 217, 239.
51Mathai E, Rolain JM, Verghese L, Mathai M, Jasper P, Verghese G, et al. Case reports: Scrub typhus during pregnancy in India. Trans R Soc Trop Med Hyg 2003;97:570-2.
52Phupong V, Srettakraikul K. Scrub typhus during pregnancy: A case report and review of the literature. Southeast Asian J Trop Med Public Health 2004;35:358-60.
53Suntharasaj T, Janjindamai W, Krisanapan S. Pregnancy with scrub typhus and vertical transmission: A case report. J Obstet Gynaecol Res 1997;23:75-8.
54Wang CL, Yang KD, Cheng SN, Chu ML. Neonatal scrub typhus: A case report. Pediatrics 1992;89:965-8.
55Briggs G, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 2 nd ed. Baltimore: Williams and Wilkins; 1986. p. 76-8.
56Tsui MS, Fang RC, Su YM, Li YT, Lin HM, Sun LS, et al. Scrub typhus and pregnancy: A case report and literature review. Zhonghua Yi Xue Za Zhi (Taipei) 1992;49:61-3.
57Kim YS, Yun HJ, Shim SY, Koo SH, Kim SY, Kim S. A comparative trial of a single dose of azithromycin versus doxycycline for the treatment of mild scrub typhus. Clin Infect Dis 2004;39:1329-35.
58Choi EK, Pai H. Azithromycin therapy for scrub typhus during pregnancy. Clin Infect Dis 1998;27:1538-9.
59Alvarez-Elcoro S, Enzler MJ. The macrolides: Erythromycin, clarithromycin, and azithromycin. Mayo Clin Proc 1999;74:613-34.